Moneycontrol

Moneycontrol PRO

you are here: HomeNewsBusinessEarningsBiocon says confident of maintaining margins in Q4

SHOW NAMES

Trending Topics

business

Biocon says confident of maintaining margins in Q4

Third quarter sales for Biocon were lower than street's expectations (Rs 700 crore vs Rs 759 crore) but EBITDA was higher. This was due to margin expansion that resulted from temporary low R&D spend, said Kiran Mazumdar-Shaw. The company would maintain margins in the fourth quarter by changing product mix and focusing on high-margin products.

first published: Jan 23, 2014 01:48 pm

LATEST VIDEOS

A collection of the most-viewed Moneycontrol videos.

Watch and Follow our leading shows

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347